Skip to main content
Abbott8-K: Governance change

Abbott launches 2026 Incentive Stock Program, authorizing 140 million shares for employee compensation.

What happened

The company is overhauling its equity compensation framework, replacing the 2017 program.

Source

SEC EDGARApr 27, 2026

Current report (Form 8-K)

Abbott 8-K

Filing excerpt

On April 24, 2026, Abbott shareholders approved the adoption of the Abbott Laboratories 2026 Incentive Stock Program (the “2026 Program”) at the Annual Meeting of Shareholders.

sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Governance change

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Apr 27, 2026

The full record

From the Signal API record

Details

CIK
1800
Accession number
0001104659-26-049434
Metric named
The value of 140,000,000 common shares authorized for the new incentive program.
Timeframe
Immediate
Filing year
2026
Why it matters
Governance tools needed
Signal category
Esg

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Apr 28, 2026
signal_type
sec-8k
signal_subtype
governanceChange

Use this data

Get every 8-K signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/930e8833-4b11-451f-9ede-79ad990fa91b returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "930e8833-4b11-451f-9ede-79ad990fa91b",
  "signal_type": "sec-8k",
  "signal_subtype": "governanceChange",
  "detected_at": "2026-04-28T10:18:14.141+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "detail": "The company is overhauling its equity compensation framework, replacing the 2017 program. This major initiative will require significant administrative, legal, and potentially technological support to manage new award types, creating opportunities for vendors in HR tech and equity plan administration.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "The value of 140,000,000 common shares authorized for the new incentive program."
    },
    "summary": "Abbott launches 2026 Incentive Stock Program, authorizing 140 million shares for employee compensation.",
    "excerpts": "On April 24, 2026, Abbott shareholders approved the adoption of the Abbott Laboratories 2026 Incentive Stock Program (the “2026 Program”) at the Annual Meeting of Shareholders.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm",
    "filing_date": "2026-04-27",
    "filing_year": 2026,
    "sales_relevance": "Governance tools needed",
    "signal_category": "esg"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.